Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Immunotherapy for HCV infection: next steps.

Lang K, Weiner DB.

Expert Rev Vaccines. 2008 Sep;7(7):915-23. doi: 10.1586/14760584.7.7.915. Review.

PMID:
18767942
2.

Immune-based therapy for chronic hepatitis C.

Chang DY, Shin EC.

J Leukoc Biol. 2009 Jul;86(1):33-9. doi: 10.1189/jlb.1208772. Epub 2009 Apr 24.

PMID:
19395471
3.

Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies.

Lauer GM.

J Infect Dis. 2013 Mar;207 Suppl 1:S7-S12. doi: 10.1093/infdis/jis762. Review.

PMID:
23390305
4.

Development of prophylactic and therapeutic vaccines against hepatitis C virus.

Leroux-Roels G.

Expert Rev Vaccines. 2005 Jun;4(3):351-71. Review.

PMID:
16026249
5.

Perspectives for a vaccine against hepatitis C virus.

Abrignani S, Houghton M, Hsu HH.

J Hepatol. 1999;31 Suppl 1:259-63. Review.

PMID:
10622599
6.

Treatment of hepatitis C in patients who have decompensated cirrhosis.

Everson GT.

Clin Liver Dis. 2005 Aug;9(3):473-86, viii. Review.

PMID:
16023978
7.

Codelivery of PEG-IFN-alpha inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys.

Park SH, Lee SR, Hyun BH, Kim BM, Sung YC.

Vaccine. 2008 Jul 29;26(32):3978-83. doi: 10.1016/j.vaccine.2008.05.017. Epub 2008 Jun 2.

PMID:
18556097
8.

Subversion of innate host antiviral strategies by the hepatitis C virus.

Bode JG, Brenndörfer ED, Häussinger D.

Arch Biochem Biophys. 2007 Jun 15;462(2):254-65. Epub 2007 Apr 16. Review.

PMID:
17467654
9.

Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine.

Thimme R, Neumann-Haefelin C, Boettler T, Blum HE.

Biol Chem. 2008 May;389(5):457-67. Review.

PMID:
18953713
10.

The status of liver transplantation for hepatitis C.

Cameron AM, Busuttil RW.

Expert Opin Biol Ther. 2006 Oct;6(10):993-1002. Review.

PMID:
16989581
11.

[Development of the novel oral vaccine against hepatitis C virus utilizing bifidobacteria].

Shirakawa T.

Nihon Rinsho. 2015 Feb;73(2):239-42. Review. Japanese.

PMID:
25764677
12.

A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.

Zeng R, Li G, Ling S, Zhang H, Yao Z, Xiu B, He F, Huang R, Wei L.

Antiviral Res. 2009 Oct;84(1):23-30. doi: 10.1016/j.antiviral.2009.07.011. Epub 2009 Jul 29.

PMID:
19646486
13.

The hepatitis C crisis.

St John TM, Sandt L.

Ethn Dis. 2005 Spring;15(2 Suppl 2):S52-7.

PMID:
15822840
14.

Acute hepatitis C: prevention and treatment.

Ozaras R, Tahan V.

Expert Rev Anti Infect Ther. 2009 Apr;7(3):351-61. doi: 10.1586/eri.09.8. Review.

PMID:
19344247
15.

Prospects for a vaccine against the hepatitis C virus.

Houghton M, Abrignani S.

Nature. 2005 Aug 18;436(7053):961-6. Review.

PMID:
16107836
16.

Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis.

Sato Y, Oya H, Yamamoto S, Kobayashi T, Watanabe T, Kokai H, Yamagiwa S, Hatakeyama K.

Hepatogastroenterology. 2009 Jan-Feb;56(89):205-7.

PMID:
19453058
17.

New developments in the antiviral treatment of hepatitis C.

de Bruijne J, Weegink CJ, Jansen PL, Reesink HW.

Vox Sang. 2009 Jul;97(1):1-12. doi: 10.1111/j.1423-0410.2009.01187.x. Epub 2009 Apr 20. Review.

PMID:
19392783
18.

[Virus C hepatitis: successful therapy in a health care worker].

Fantini S, Zarelli L, Tomao P, Vonesch N, Signorini S, Martini A.

G Ital Med Lav Ergon. 2007 Jul-Sep;29(3 Suppl):763-4. Italian.

PMID:
18409947
19.

Hepatitis C virus virology and new treatment targets.

Meier V, Ramadori G.

Expert Rev Anti Infect Ther. 2009 Apr;7(3):329-50. doi: 10.1586/eri.09.12. Review.

PMID:
19344246
20.

Prevention of hepatitis C virus infection.

Koff RS.

Clin Liver Dis. 1997 Nov;1(3):603-13. Review.

PMID:
15560061

Supplemental Content

Support Center